Baseline IPSS-M vs pretransplant risk downstaging as prognostic determinants in MDS undergoing allogeneic transplantation.

Although patients with substantial improvements in their IPSS-M scores post-HMA therapy demonstrated numerically higher survival after transplant (38% vs 23%), this difference did not reach statistical significance, likely reflecting the limited sample size within each subgroup.

also in 111,027 other papers